Breast cancer drug may protect heart
The breast cancer drug tamoxifen was shown to reduce levels of key inflammatory markers that have been linked to an increased risk of heart disease, researchers have reported in Arteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association.
Tamoxifen is in a class of drugs known as selective estrogen receptor modulators. The drug has been shown to reduce the incidence of breast cancer in healthy women a...
Oops! An active online subscription is required to access this content.
Please login below or Subscribe today!